Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Franklin Covey Co. (NYSE: FC) is successfully navigating the final stages of its sales force restructuring and business model transition. While reported GAAP profitability has faced near-term pressure due to restructuring charges and stock-based compensation, leading indicators such as invoiced amounts (up 7% for consecutive quarters in Enterprise North America) and deferred revenue (up 7% to $101.5 million) point to a strong growth inflection. The company's highly scalable subscription model (76% gross margins) and robust balance sheet with over $76 million in liquidity position it well to accelerate reported revenue and expand EBITDA margins significantly heading into FY27.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets3 analysts · as of 18 Aug 2026
Low · most bearish analyst$25.00
Mean target$31.00
High · most bullish analyst$38.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$22.0020%

Macroeconomic headwinds contract corporate L&D budgets, leading to lower renewal rates for the All Access Pass (AAP). Sales rep attrition rises following the restructuring, causing invoiced growth to stall or turn negative, while government contract cancellations persist.

Base CaseCentral scenario
$30.0050%

Franklin Covey executes in line with reaffirmed FY26 guidance of $265M-$275M in revenue and $28M-$33M in Adjusted EBITDA. Invoiced amounts continue to grow at a steady 5-7% pace, and multi-year contract mix remains stable at ~62%, supporting a gradual re-rating of the stock as GAAP earnings turn positive in FY27.

Bull CaseUpside scenario
$38.0030%

The specialized sales force achieves maximum productivity, driving Enterprise North America invoiced growth into double digits. The Education Division continues its high-margin expansion (16% growth in Q2 FY26), and the conversion of deferred revenue accelerates. Operating leverage kicks in, expanding Adjusted EBITDA margins toward 15% and driving the stock to the high end of analyst targets.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • High-margin subscription model with gross margins stable at approximately 76%, providing strong operating leverage.
  • Robust leading indicators with deferred revenue climbing to $101.5 million and North American invoiced amounts growing 7% for consecutive quarters.
  • Strong balance sheet with negligible debt ($0.8M) and over $76 million in total liquidity, supporting active share buybacks ($17M repurchased in Q2 FY26).
Sign in / Sign up to read more
Key Investment Risks
  • Near-term GAAP net losses driven by restructuring costs and elevated stock-based compensation.
  • Sensitivity of corporate training budgets to macroeconomic downturns and corporate cost-cutting cycles.
  • Execution risks associated with the newly restructured, specialized sales force GTM strategy.
Sign in / Sign up to read more
Thesis Invalidation Triggers
  1. A decline in North American AAP multi-year contract mix below 55%.
  2. Consecutive quarters of flat or negative invoiced amounts growth in the Enterprise Division.
  3. Failure to achieve the lower bound of FY26 Adjusted EBITDA guidance ($28 million).
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.